SCHEMBL4982880

SCHEMBL4982880

Nc1ncnc2c1CCN(S(=O)(=O)c1ccc(Oc3ccc(C(F)(F)F)cc3)cc1)C2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.42
HSD11B1 P28845 1/20 0.41
NOX4 Q9NPH5 2/20 0.40
SCN9A Q15858 4/20 0.40
HDAC6 Q9UBN7 1/20 0.40
ALDH1A1 P00352 1/20 0.39
KDM4E B2RXH2 1/20 0.39
CCR6 P51684 1/20 0.38
LMNA P02545 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
GAA P10253 2/20 0.38
JAK2 O60674 1/20 0.37
JAK1 P23458 1/20 0.37
KMT2A Q03164 1/20 0.37
USP2 O75604 1/20 0.37
POLB P06746 1/20 0.37
HTT P42858 1/20 0.37
MAPK10 P53779 1/20 0.37
TRPV1 Q8NER1 1/20 0.37
MKNK1 Q9BUB5 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4987934 0.94 HSD11B1 (0.45) L3MBTL1HSD11B1SCN9AHDAC6ALDH1A1
SCHEMBL4985250 0.89 LMNA (0.40) ALDH1A1LMNASMN1; SMN2KMT2AHTT
SCHEMBL4980965 0.88 SMN1; SMN2 (0.49) ALDH1A1LMNASMN1; SMN2KMT2AHTT
SCHEMBL4983071 0.86 PKM (0.48) L3MBTL1HSD11B1ALDH1A1KDM4ELMNA
SCHEMBL4985230 0.86 MEN1 (0.43) SCN9AHDAC6KMT2A
SCHEMBL4980438 0.83 MMP1 (0.40) ALDH1A1LMNASMN1; SMN2KMT2AHTT
SCHEMBL4987016 0.83 PKM (0.51) L3MBTL1HSD11B1ALDH1A1KDM4ELMNA
SCHEMBL4989425 0.82 MMP2 (0.40) ALDH1A1KDM4ELMNASMN1; SMN2KMT2A
SCHEMBL4982847 0.82 LMNA (0.41) ALDH1A1LMNASMN1; SMN2KMT2AMKNK1
SCHEMBL4987060 0.82 HTT (0.48) L3MBTL1HSD11B1SCN9AKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof RENOVIS, INC. 2008-02-14 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 L3MBTL1 4476/4885HSD11B1 3494/4885NOX4 831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.